Abstract

Introduction: The emerging resistance to Carbapenems which are generally considered as life saving drugs to treat infections caused by ESBL and AmpC producing bacteria, has become a serious issue worldwide. It is therefore necessary to detect Carbapenemases to limit the spread of multidrug resistant organisms for effective Antibiotic surveillance and Infection Control in the Hospital.

Aim & Objectives: To detect the presence of MBL, KPC Carbapenemase and their Co-Existence among the Carbapenem resistant clinical isolates of Gram Negative Bacilli

Materials & Methods: The present study was carried out in a Tertiary care hospital; to detect Carbapenamases among Gram Negative Bacilli by Inhibitor based combined Disc tests in which Phenylboronic Acid and Dipicolinic acid are incorporated onto Meropenem discs.

Results:  A Total of 718 strains of Gram Negative Bacilli comprising of 516 strains of Enterobacteriaceae and 202 Non-fermenters were included in the study. Out of these 718 strains, 89 strains were resistant to carbapenems, of which 2.5% (18 /718) were KPC (Klebsiella Pneumoniae Carbapenemase –class A) producers, 8.08%(58/718)  were MBL (Metallo Beta Lactamases-class B) producers .Co-existence of MBL and KPC was observed in  1.25% (9 /718) of isolates and no mechanism was detected in 4 isolates.

Conclusion: Inhibitor based combined disc test is simple and cost effective phenotypic test for detecting Carbapenem resistance in the Laboratory. Antibiotic stewardship programme has to be implemented in Hospital to achieve good Infection control for better patient outcome and reduce the health care costs.

Key words: Carbapenemase, KPC, MBL, Enterobacteriaceae, Non-fermenters.

1.      Carlos M. Luna, Eduardo Rodriguez-Noriega, Luis Bavestrello and Manuel-Guzman-Blanco (2014). Gram-Negative Infections in adult ICUs of Latin America and the Caribbean. Critical Care research and Practice; 2014:1-12.

2.      Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB, Patwardhan NS. Metallo-β-lactamase-producing clinical isolates from patients of a tertiary care hospital. J Lab Physicians 2011;3(2):93-97

3.      Chang-Seop Lee , Yohei Do , Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens, Infect Chemother. 2014 Sep; 46(3): 149–164.

4.      Varaiya A, Kulkarni M, Bhalekar P, Dogra J. Incidence of Metallo‐beta lactamase producing Pseudomonas aeruginosa in cancer and diabetic patients. Indian J Pathol Microbiol 2008; 51(2):200-203.

5.      Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerging Infect Dis. 2011; 17(10):191-97.

6.      F.G.Collee, RS Miles, B Watt. Tests for the Identification of Bacteria. In:JG Collee, AG Fraser, BP Marmion.A Simmons,editors.Mackie & McCartney Practical Medical Microbiology.14^th ed.Edinburg, UK:Churchill Livingstone ;2006.p.131-150

7.      Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S26-U. Wayne, PA: CLSI; 2016.

8.      J.B.Casals,M.Pandrup Duer-Jensen. Phenotypic method for the detection of metallo-beta-lactamases and KPC carbapenemases in the same isolate of Enterobacteriaceae.21^st European Congress of Clinical Microbiology and Infectious Diseases,27^th  International Congress of Chemotherapy:2011 May 7-10;Milan,Italy

9.      Noyal MJ, Menezes GA, Harish BN, Sujatha S, Parija SC. Simple screening   tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res 2009; 129:707-12.

10.  Shivesh P. Carbapenem sensitivity profile amongst bacterial isolates from clinical    specimens in Kanpur city. Indian J Crit Care Med 2006; 10(4):250-53.

11.  Shashikala, Kanungo R, Srinivasan S, Devi S. Emerging resistance to carbape-nems in hospital acquired Pseudomonas infection: A cause for concern. Indian J Pharmacol 2006; 38:287-88.

12.  Datta P, Gupta V, Garg S, Chander J. Phenotypic method for differentiation of Carbapenemases in Enterobacteriaceae: Study from North India. Ind J Pathol Microbiol. 2012; 55:357-60.

13.  Peleg AY, Franklin C, Bell JM, Spelmann DW. Dissemination of the metallo-β-lactamase gene bla IMP4 among gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis 2005; 41: 1549-1556.

14.  Nordmann P, Poirel L. Emerging carbapenemases in gram-negative aerobes. Clin Microbial Infect 2002; 8:321-331.

15.  Walsh TR, Toleman MA, Poirel L, Nordman P. Metallo β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18: 306-325.

16.  Garza-Ramos U, Morfin-Otero R, Sader HS, Jones RN, Hernández E, Rodriguez-Noriega E, et al. Metallo-β lactamase gene blaIMP-15 in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother, 2008; 52:2943–6.

17.  Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, et al. Molecular characterization of SPM-1, a novel metallo-β- lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother. 2002; 50:673–9.

18.  Moayednia R, Shokri D, Mobasherizadeh S, Baradaran A, Fatemi SM, Merrikhi A. Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. J Res Med Sci, 2014; 19(Suppl 1):S415.

19.  Bhattacharya D, Thamizhmani R, Bhattacharya H, Sayi DS, Muruganandam N, Roy S, et al. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India. Microb Drug Resist, 2013; 19(6):457-62.

20.  Saha R, Jain S, Kaur IR. Metallo beta-lactamase producing pseudomonas species--a major cause of concern among hospital associated urinary tract infection. .J. Indian Med Assoc, 2010; 108(6):344-8.

21.  D G Deshmukh, A S Damle, J K Bajaj, J B Bhakre, N S Patwardhan. Metallo- β-lactamase-producing Clinical Isolates from Patients of a Tertiary Care Hospital. J Lab Physicians, 2011; 3(2): 93–97.

22.  Varaiya, N. Kulkarni, M. Kulkarni, P. Bhalekar, J Dogra. Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients. Indian J Med Res, 2008; 127:398-402.

23.  Dardi Charan Kaur, Prevalence of Metallo-β-lactamase in Gram negative uropathogens from a Tertiary Care rural Hospital, Medical Science, 2015, 17(67), 11-15,

24.  Rajkumar MS, Soma S, Puranjay S, Manideepa S. Carbapenemase producing Enterobacteriaceae among urinary isolates: Scenerio from a tertiary care hospital in Eastern India. Journal Evolution Med Dental Sci 2014 February 10; 3(6):1323-333.

25. C.GGiske,L.Gezelius,O.Samuelsen,M.Warner,A.Sundsiford,N.Woodford.A sensitive and specific phenotypic assay for detection of metallo- β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with phenylboronicacid,dipicolinic acid and cloxacillin.Clin Microbiol Infect 2011;17:552-56

26.  Christine Seah et al,Comparative Evaluation of a Chromogenic Agar Medium, the Modified Hodge Test and a  Battery of  Meropenem-Inhibitor Discs for Detection of Carbapenemase Activity in Enterobacteriaceae, JCM  May 2011;p;1965-1969

27.  Gupta V, Datta P, Chander J. Prevalence of metallo-beta-lactamase (MBL) producing Pseudomonas spp and Acinetobacter spp in a tertiary care hospital in India. J Infect 2006; 52:311-314.

28.  Jesudason MV, Kandathil AJ, Balaji V. Comparison of two methods to detect carbapenemase and metallo-beta-lactamase production in clinical isolates. Indian J Med Res 2005; 121:780-783.

29.  Chakraborty D, Basu S, Das S. A study on infections caused by metallo-beta- lactamase producing gram negative bacteria in intensive care unit patients. Am J Infect Dis 2010; 6:34-39.

30.  Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB, Patwardhan NS. Metallo-β-lactamase-producing clinical isolates from patients of a tertiary care hospital. J Lab Physicians 2011; 3(2):93-97.

31.  Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R. New Delhi Metallo-beta-lactamase (NDM-1) in Enterobacteriaceae: Treatment options with Carbapenems Compromised. J Assoc Physicians Ind 2010; 58:147-149.

32.  Rai S, Manchanda V, Singh NP, Kaur IR. Zinc-dependent carbapenemases in clinical isolates of family Enterobacteriaceae. Ind J Med Microbiol 2011; 29(3):275-279.